Editorial

Biopharmaceutical companies are undergoing substantial transformations. The rising costs of healthcare, the rapidly expanding generics market and new regulations are deeply impacting the dynamics of drug innovation and the reimbursement of new treatments. Biomedical breakthroughs are paving the way for increasingly targeted medicines, vaccines, new diagnostic technologies and cell therapies for which economic models will need to be invented. Now more than ever, therapeutic innovation has become the core challenge for biopharmaceutical companies. How can this field be stimulated, its products marketed, and its benefits distributed widely and fairly across society?

Since its creation in 2003, the ESSEC Chair of Therapeutic Innovation aims to meet two objectives: 1/ train future health industry decision makers in innovation management; 2/ develop strategic analyses to transform therapeutic disruptive technologies into economic and social progress. Each year, the Chair welcomes international graduate and post-graduate students from a wide variety of backgrounds seeking to steer their career towards the healthcare sector. In addition to its teaching activities, the Chair conducts socio-economic studies and strives to create a stimulating laboratory of ideas, a space for free forward thinking on the impact that these biomedical innovations will have over the next decade.

Agenda

Graduation Ceremony Class of  2011
Thursday, March 22nd 2012, at 6.30 pm
ESSEC Campus at La Défense